Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease

por Yechiel, Yaniv, Orr, Yaly, Gurevich, Konstantin, Gill, Ronit, Keidar, Zohar
Publicado 2023

68Ga-labeled PSMA-11 (68Ga-isoPROtrace-11) synthesized with ready to use kit: normal biodistribution and uptake characteristics of tumour lesions

por Kurash, Marina Muchnik, Gill, Ronit, Khairulin, Maria, Harbosh, Hanan, Keidar, Zohar
Publicado 2020

[F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients

por Gill, Ronit, Abdah-Bortnyak, Roxolyana, Amit, Amnon, Bar-Peled, Uval, Keidar, Zohar
Publicado 2022

68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls

por Keidar, Zohar, Gill, Ronit, Goshen, Elinor, Israel, Ora, Davidson, Tima, Morgulis, Maryna, Pirmisashvili, Natalia, Ben-Haim, Simona
Publicado 2018